Febrile Neutropenia

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/35

encourage image

There's no tags or description

Looks like no tags are added yet.

36 Terms

1
New cards

Neutrophils:

  • type of white blood cell (WBC) and essential component of ______ immune system

  • responds to invading ______

  • DIRECTLY attacks _______ and _______

  • release _______ to produce inflammatory repsonse at site of infection


  • inate

  • pathogens

  • bacteria and fungi

  • cytokine


2
New cards

what is the parameter describing the number of neutrophils in the body

Absolute Neutrophil Count (ANC)

3
New cards

Neutropenia is ANC less than ______

1500 cells/nL

4
New cards

what is considered severe neutropenia?

ANC less than 500 cells/hl


OR


ANC< 1000 cells/hl AND predicted to decline 500 cells/hl or less over the next 48 hours (2 days)

5
New cards

risk of infection increases with the _____ and ______ or neutropenia

duration and degree

6
New cards

infection risk in the highest in those with _____ and _____ nuetropenia

  • prior to ________ during hematopeitic cell transplantation

  • after _____ therapy for acute eleukemia


profound (<100) and prolonged

  • prior to engraftment

  • after induction therapy


7
New cards

febrile neutropenia is also called _______ ________

is it considered a medical emergency?

neutropenic fever

YES

8
New cards

what makes someone considered to have febrile neutropenia?

SEVERE neutropenia (<500 or <1000 predicted to decline to <500 in 48 hours)


PLUS


oral temp (38.8C+ = 101F+ )

temperature (38+ or 100.4F+) sustained over an HOUR

9
New cards

is febrile neutropenia a common or rare complication in patients recieving cancer therapy?

which cancers is it more common in?

NO it is common

10-15% of patients with solid tumors

80% patients with hematologic malignancies

10
New cards

epidemiology:

  • Complications occur in 25-30% of cases in patients with

    • _______, renal, respiratory, heart failure

  • mortality rate up to 11%

  • An important cause of healthcare resource consumption


hypotension

11
New cards

effect of cytotoxic chemotherapy or hematopetic progenitor cells

most important risk factor for infection

neutropenia

12
New cards

what are some factors that predispose patients to infections?

  • neutropenia

  • mucousal barrier injury

  • dysbiosis


13
New cards
  • effect of cytoxic chemotherapy on epitherlial cells of the MOUTH and GI tract (manifests as _____)

  • portal of entry for bacteria into the blood stream


mucousal barrier injjury

14
New cards

gut microbiota altered by certain chemotherapy agents

total body irridaiation

antimicrobial prophylaxis- use


colonization with nosocomial organisms such as pseudomonas aerginosa and yeast overgrowth

dysbiosis

15
New cards

Microbiology:

  • Infectious etiology is identified in only 40- 50%.

  • Most infections are caused by endogenous/exogenous flora

  • Gram-positive and Gram-negative ______ are the predominant pathogens

  • ______ are late causes of infection in severely immunocompromised hosts


  • endogenous flora

  • bacteria

  • fungi - late cuases of infection


16
New cards

which gram negative bacteria causes SEVERE infections?

why are gram positive febrile neutropenias frequent?

gram negative = psudomonas aerugonomas

gram positive = central venous catheters + fluroquinolones prophylaxis

17
New cards

what are common gram negative aerobic bacteria?

  • escherichia coli

  • klebsiella spp.

  • psuedomonas auerginosa

  • other enterobacterales


18
New cards

Clinical Presentation:

  • _______ is usually the first and ONLY sign of infection

  • classic signs of infection may be absent due to impaired _______ response

  • infection can progress ________


fever

inflammatory

rapidly

19
New cards

_____ in the setting of neutropenia is considered a sign of infection until proven otherwise

fever in neutropenia = INFECTION

20
New cards

What are three types of infections?

  • microbiologically documented infections

  • clinically documented infections

  • fever of unknown origin


21
New cards

What are some diagnostic and labroatory testing for Febrile Neutropenia?

  • CBC with differential

  • chemistry tests (electrolytes + renal + hepatic)

  • History and physical examination

    • Classic signs of infection may be attenuated or absent

    • Common sites should be assessed

  • Two sets of blood cultures

  • chest radiograph


22
New cards

Risk assessment:

  • predicts probability of ______ __________


Risk stratification concepts

  • Most patients receiving treatment for ______ _______ are considered LOW RISK (druation of neutropenia < 7 days)


  • most patients receieving treatment for ________ ________ are considered HIGH RISK (neutropenia for ___ or more days!)


  • Determines whether or not treatment should be adminsitered ________ or ______


  • serious complications


  • LOW RISK = Solid tumors (neutropenia less than 7 days)

  • HIGH RISK = Hematologic malignancies (neutropenia for more than 7 days)


  • Inpatient or outpatient


23
New cards

Low-Risk (ALL of the following must be present):

  • MASC score ___+ or CISNE less than _____

  • _____ status

  • NO associated ______ ilness requiring hopsitalizations

  • anticipated short duration of severe neutropenia (less than __ days)

  • good preformance status of ________

  • no ______ or _____ insufficiency


  • MASC 21+ CISNE less than 3+

  • outpatient

  • comorbid

  • 7 days

  • ECOG 0-1

  • heaptic or renal


24
New cards

High-Risk (1+ of these present):

  • MASCC less than ___ or CISNE greater than ____

  • ______ status

  • significant _____ illness or clinically unstable

  • anticipated prolonged of severe neutropenia (____ or more days)

  • uncontrolled/progessive cancer

  • ________ or other complex infections at clinical presentation

  • _______ or hematologic malignancy


  • less than 21 or 3+

  • inpatient

  • comorbid

  • 7+ days of neutropenia

  • pneumonia

  • HSCT (hematopoietic stem cell transplantation)


25
New cards

High-risk patients (MASC <21 and CISNE 3+)

  • Require _________ and IV _________


Low- risk patients (MASC 21+ and CISNE < 3)

  • may be treated in the outpatient setting with _____ or _____ _________ if no logistical barriers such as

    • residence in close proximity to a medical facility

    • family member or caregiver at home

    • access to a telephone + transportation


High risk

  • hospitalizations and IV antimicrobials


Low risk:

  • PO or IV antimicrobials


26
New cards

Principles of Antimicrobial Therapy:

  • _____ in a patient with neutropenia from cancer therapy should be assumed to be due to infection until proven otherwise


  • patients should be assesed soon (within ___ minutes) after presenting with febrile neutrotoxicity


  • first dose of empiric antimicrobials should be administered within ____ minutes


  • empirical antimicrobials regimens should ALWAYS cover ______ _______


  • fever

  • within 15 minutes

  • 60 minutes

  • psuedomonas aeuroginosa


27
New cards

Empiricic therapy in high risk patients:

  • monotherapy of IV anti- _________ _____________ such as

    • _________

    • _________

    • __________

    • ___________


anti-psuedomonal BETA-LACTAM

  • pip/tazo (zosyn)

  • cefepime

  • meropenen

  • imipenem/cilastin


28
New cards

HIGH RISK antibiotics:

Choice of beta-lactam guided by previous infection, current symtoms, and institutional antibiogram

  • regimens with ______ activity IF patient is experiencing abdominal pain or diarhea

  • _______ preffered if colonized with ESBL producing enterobacteriales


  • anaerobic activity

  • carbapenems


29
New cards

HIGH risk antibiotics:

  • Is vancomycin recommended as a standard part of the initial antibiotic regimen?

  • why or why not?


  • NO; consider it ONLY if specific clinical indications NOT empirically

  • will NOT imporve survival + gram + vacteremias rarely cause rapid demise in patients with febrile neutropenia EXCEPT viridans group streptococcus


vacomycin could increase risk of RESISTANCE and NEPHROTOXICITY


30
New cards

When WOULD you add vancomycin to high risk patient therapy if not empirically?

  1. colonization with MRSA or penecillin resistance streptococus pneumonae

  2. skin and soft-tissue infection

  3. pneumonia

  4. catheter IV related infection

  5. blood culture POSITIVE for GRAM POSITIVE bacrteia before final identification and suceptibilties

  6. clinical INSTABILITY (hypotension, shock)


31
New cards

Empiric Therapy in LOW risk Patients:

  • first does of IV antimicrobials administered in medical facility

  • choice of IV antimicrobials simmilar to high risk partients (anti-psuedomonal beta lactam)

  • observed for __+ hours before discharge

  • transitions to PO_________ based regimen on discharge


  • observed for 4+ hours before discharge

  • trasntition from IV antipsuedomonal beta lactam —> PO fluroquinolone on discharge



PO fluoroquinolone examples:

  • ciprofloxacin + amoxicillin clavulanate (preferred)

  • ciprofloxacin + clindamycin

  • levofloxicin

  • moxifloxacin


32
New cards

Can low risk patients be given PO fluroquinolones upon discharge if they have recieved fluroquinolone prophylaxis?

NO

33
New cards

Follow-up therapy HIGH RISK:

  • vancomycin (if inititated) can be discontinued after ___ _____ if no resistant gram-positive organisms


  • Patients who become hemodynamically unstable should have their antimicrobial regimens broaded/ more specific


  • Empiric fungal therapy considered for patients with persistent fever of ____- ____ days


  • 48 hours

  • Broader if becomes hemodynamically unstable

  • 4-7 days


34
New cards

Follow-up therapy LOW RISK:

  • outpatients do not devervesce (recompensate fever) after ___- ____ hours of antibiotics may require hospitalization


48 -72 hours


2-3 days

35
New cards

Duration of Therapy:

  • Microbiologically active or clinically documented infections=

    • treatment is continued until a standard course of therapy has been completed and ANC is greater than _______ cells/hL


  • Fever Of Unknown Origin:

    • treatment continued until afebrile for ___+ days and ANC is _____+ cells/hL

    • Treatment discontinued after __+ of IV antibiotics and afebrile for __+ days irrespective of ANC (± transition to fluroquinolone prophylaxis)


microbiologically active

  • 500+


fever of unknown origin

  • 2+ days AND ANC 500+ OR

  • 3+ days of antibiotics and afebrile for 2+ days REGARDLESS of ANC (± trasntiiton to fluroquinolone prophylaxis)


36
New cards

Summary:

  • febrile neutropenia (neutropenic fever) is a ______ ______

  • ______ is often the ONLY sign of infection which can progress RAPIDLY

  • empiric therapy in high risk patients consists of an ____ __________ ________

  • _______ is only added added in high risk patients in speicifc clinical situations

  • Empiric therapy in LOW RISK paitents —> _____ ________


  • medical emergency

  • fever

  • high risk empiric = anti- psuedomonal beta lactam

  • vancomycin

  • PO fluroquinolones (cirpofloxacin + amoxicillin clavulonate)